LivaNova (LIVN) Stock News
$LIVN · NASDAQ · HEALTHCARE · 5 stories in 30 days$82.50
1D +3.25%
BORSA has published 5 stories on LivaNova (LIVN) in the past 30 days. BORSA’s news read on LIVN is bullish at 67/100, based on 5 company events over the past 7 days. LivaNova last reported quarterly results on Aug 5, 2026, for the quarter ended Jun 30, 2026.
The wire on $LIVN
newest first · updated · direct subject stories onlyLivaNova lifts 2026 adjusted EPS view to $4.40-$4.50
LivaNova lifted its 2026 adjusted EPS guidance to $4.40-$4.50. The raise points to stronger expected profitability for the medical device maker.
bullish 70 · impact 40LivaNova lifts full-year 2026 revenue growth guidance to 9-10% constant currency
LivaNova raised its full-year 2026 revenue growth guidance by 100 basis points to 9-10% on a constant-currency basis. The upgrade points to stronger demand and operational momentum for the medical-device company.
bullish 75 · impact 60